{"result": "(\"entity\"<|>GALE<|>PERSON<|>GALE is a gene located on chromosome 1p36 that is responsible for the metabolism of galactose and is associated with various clinical deficits in individuals.)\n##\n(\"entity\"<|>GALACTOSEMIA<|>EVENT<|>Galactosemia is a metabolic disorder characterized by the inability to properly metabolize galactose, leading to various clinical symptoms and complications.)\n##\n(\"entity\"<|>GALACTOSE<|>PERSON<|>Galactose is a monosaccharide that is part of the galactolipids and is involved in the metabolism processes described in the document.)\n##\n(\"entity\"<|>FRUCTOSE<|>PERSON<|>Fructose is a monosaccharide found in fruits and honey, and is often included in manufactured products as a sweetener.)\n##\n(\"entity\"<|>FRUCTOSE-1,6-FOSFATO ALDOLASA<|>PERSON<|>Fructose-1,6-fosfato aldolasa is an enzyme that plays a crucial role in the metabolism of fructose and is linked to hereditary fructose intolerance.)\n##\n(\"entity\"<|>ALDOB<|>PERSON<|>ALDOB is a gene located on chromosome 9q22.3 that encodes the enzyme fructose-1,6-fosfato aldolasa, which is essential for fructose metabolism.)\n##\n(\"relationship\"<|>GALE<|>GALACTOSEMIA<|>The GALE gene is involved in the metabolism of galactose, which is directly related to the condition of galactosemia.<|>7)\n##\n(\"relationship\"<|>GALACTOSE<|>GALACTOSEMIA<|>Galactose is a key component in the metabolic disorder known as galactosemia, where its metabolism is impaired.<|>8)\n##\n(\"relationship\"<|>FRUCTOSE<|>FRUCTOSE-1,6-FOSFATO ALDOLASA<|>Fructose metabolism is dependent on the enzyme fructose-1,6-fosfato aldolasa, which is crucial for processing fructose.<|>9)\n##\n(\"relationship\"<|>ALDOB<|>FRUCTOSE-1,6-FOSFATO ALDOLASA<|>The ALDOB gene encodes the enzyme fructose-1,6-fosfato aldolasa, linking genetic information to fructose metabolism.<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: oproteínas y galactolípidos (como los cerebrósidos). Es expresada por el gen GALE (1p36) y su déficit se hereda de forma autosómica recesiva. Se han descrito tres formas clínicas:\n\na. Déficit periférico: Limitado a los eritrocitos y leucocitos circulantes. Los individuos son asintomáticos, tienen un desarrollo normal y no precisan tratamiento nutricional específico. Presentan elevación de Gal-1-P eritrocitaria y niveles normales de galactosa plasmática y galactitol urinario.\n\nb. Déficit generalizado: La actividad GALE es deficiente en todos los tejidos y se asemeja clínicamente a la galactosemia clásica. El pronóstico a largo plazo no está claro dados los pocos casos publicados, pero parece que se producen complicaciones similares. Se postula que el déficit de galactoproteínas y galactolípidos puede estar implicado en la fisiopatología de la enfermedad.\n\nc. Déficit intermedio: La actividad GALE es deficiente en eritrocitos y leucocitos y menor del 50% en el resto de los tejidos. Los individuos están libres de las manifestaciones agudas clásicas durante el período neonatal, pero no está claro si a largo plazo se producen secuelas.\n\nLos pacientes con cualquiera de estos tres fenotipos dan positivo en el screening neonatal de galactosemia cuando se cuantifica la galactosa plasmática total o la Gal-1-P eritrocitaria, pero se diferencian de la galactosemia clásica en que la actividad GALT es normal. El diagnóstico se realiza mediante la cuantificación de la actividad GALE, que está disminuida en eritrocitos en los tres fenotipos descritos, y también en fibroblastos y hepatocitos en el déficit generalizado e intermedio. La confirmación viene dada por el estudio genético.\n\n#### 2.4.2. Objetivos nutricionales y recomendaciones dietéticas\n\nLos individuos que presentan la forma periférica no precisan tratamiento. Los pacientes con la forma generalizada deben seguir una dieta limitada en galactosa, aunque no requieren que ésta sea tan estricta como en la galactosemia clásica, ya que la síntesis endógena de este monosacárido está bloqueada. Esto significa evitar los productos lácteos y sus derivados, pero está permitido el consumo de los alimentos no lácteos que contienen galactosa (cuya absorción además está cuestionada, como vimos en la galactosemia clásica). Los pacientes con la forma intermedia también deben llevar una dieta limitada en galactosa al menos durante la lactancia, y dado que no queda claro el pronóstico a largo plazo, en general se suele mantener la restricción durante años. No obstante, puede realizarse una prueba de liberalización de la dieta durante 2 semanas y determinar los niveles de Gal-1-P y galactitol urinario para decidir si es preciso mantenerla.\n\n### 3. Errores del metabolismo de la fructosa\n\nLa fructosa es un monosacárido que se encuentra ampliamente distribuido de forma natural en las frutas y también en la miel y algunas verduras. En las últimas décadas se ha ido incluyendo cada vez con mayor frecuencia en productos manufacturados por ser el azúcar más dulce, sobre todo en forma de jarabe de maíz rico en fructosa, high fructose corn syrupe (HFCS).\n---\nTema 14. Soporte nutricional en patologías con alteración en el procesamiento... 229\n\nAdemás, también son fuente de este monosacárido los alimentos que contienen sacarosa, pues de su hidrólisis se obtiene fructosa, o aquellos con sorbitol, ya que es transformado en fructosa en el hígado (figura 4).\n\nLa vía de utilización de la fructosa es diferente en el tejido hepático y muscular, aunque en ambos su destino fundamental es la obtención de energía mediante su transformación en sustratos que se incorporan a la glucólisis. En caso de ser necesario es posible la producción de glucosa (con la acción de las enzimas de las últimas etapas de la gluconeogénesis) y por lo tanto también de glucógeno. Al igual que sucede con la glucosa, los sustratos intermedios pueden derivarse además hacia la síntesis de triglicéridos si se saturan las otras rutas metabólicas.\n\n## 3.1. Déficit de fructosa-1-fosfato aldolasa o intolerancia hereditaria a la fructosa\n\n### 3.1.1. Fisiopatología y diagnóstico\n\nEs una enfermedad autosómica recesiva producida por el déficit de la isoforma B (hepática) de la fructosa-1,6-fosfato aldolasa (gen ALDOB, 9q22.3), enzima que hidroliza la fructosa-1-f\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}